UBS Group AG Sells 7,340 Shares of Invesco S&P MidCap 400 Revenue ETF $RWK

UBS Group AG cut its stake in shares of Invesco S&P MidCap 400 Revenue ETF (NYSEARCA:RWK) by 8.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 77,103 shares of the company’s stock after selling 7,340 shares during the quarter. UBS Group AG owned 0.92% of Invesco S&P MidCap 400 Revenue ETF worth $9,750,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of RWK. Farther Finance Advisors LLC purchased a new position in shares of Invesco S&P MidCap 400 Revenue ETF in the 4th quarter worth about $30,000. Flagship Harbor Advisors LLC purchased a new position in shares of Invesco S&P MidCap 400 Revenue ETF in the 4th quarter worth about $65,000. MAI Capital Management purchased a new position in shares of Invesco S&P MidCap 400 Revenue ETF in the 3rd quarter worth about $87,000. Sunbelt Securities Inc. purchased a new position in shares of Invesco S&P MidCap 400 Revenue ETF in the 3rd quarter worth about $109,000. Finally, Private Wealth Management Group LLC purchased a new position in shares of Invesco S&P MidCap 400 Revenue ETF in the 4th quarter worth about $114,000.

Invesco S&P MidCap 400 Revenue ETF Trading Down 1.8%

RWK opened at $136.03 on Friday. Invesco S&P MidCap 400 Revenue ETF has a 12-month low of $109.80 and a 12-month high of $143.32. The stock has a market capitalization of $1.18 billion, a P/E ratio of 14.05 and a beta of 1.08. The stock has a 50-day moving average price of $133.05 and a 200-day moving average price of $130.93.

Invesco S&P MidCap 400 Revenue ETF Profile

RevenueShares Mid Cap ETF (the Fund) seeks to achieve its investment objective of outperforming the total return performance of the S&P MidCap 400 Index (S&P 400) by investing in the constituent securities of the S&P 400 in the same proportions as the RevenueShares Mid Cap Index. The Fund consists of the same constituent securities as the S&P 400. But rather than being weighted by market capitalization, the Fund employs a patent-pending investment methodology to weight stocks by annual revenue. The Fund is rebalanced annually.